306 related articles for article (PubMed ID: 35588987)
1. Understanding the contributions of VPS35 and the retromer in neurodegenerative disease.
Williams ET; Chen X; Otero PA; Moore DJ
Neurobiol Dis; 2022 Aug; 170():105768. PubMed ID: 35588987
[TBL] [Abstract][Full Text] [Related]
2. VPS35 and retromer dysfunction in Parkinson's disease.
Rowlands J; Moore DJ
Philos Trans R Soc Lond B Biol Sci; 2024 Apr; 379(1899):20220384. PubMed ID: 38368930
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of
Sargent D; Moore DJ
Int Rev Mov Disord; 2021; 2():221-244. PubMed ID: 35497708
[TBL] [Abstract][Full Text] [Related]
4. The Vps35 D620N mutation linked to Parkinson's disease disrupts the cargo sorting function of retromer.
Follett J; Norwood SJ; Hamilton NA; Mohan M; Kovtun O; Tay S; Zhe Y; Wood SA; Mellick GD; Silburn PA; Collins BM; Bugarcic A; Teasdale RD
Traffic; 2014 Feb; 15(2):230-44. PubMed ID: 24152121
[TBL] [Abstract][Full Text] [Related]
5. VPS35, the Retromer Complex and Parkinson's Disease.
Williams ET; Chen X; Moore DJ
J Parkinsons Dis; 2017; 7(2):219-233. PubMed ID: 28222538
[TBL] [Abstract][Full Text] [Related]
6. Retromer binding to FAM21 and the WASH complex is perturbed by the Parkinson disease-linked VPS35(D620N) mutation.
McGough IJ; Steinberg F; Jia D; Barbuti PA; McMillan KJ; Heesom KJ; Whone AL; Caldwell MA; Billadeau DD; Rosen MK; Cullen PJ
Curr Biol; 2014 Jul; 24(14):1670-1676. PubMed ID: 24980502
[TBL] [Abstract][Full Text] [Related]
7. An update on cellular and molecular determinants of Parkinson's disease with emphasis on the role of the retromer complex.
Macías-Calvio V; Fuentealba LM; Marzolo MP
J Neurosci Res; 2021 Jan; 99(1):163-179. PubMed ID: 32633426
[TBL] [Abstract][Full Text] [Related]
8. VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson's disease.
Chen X; Tsika E; Levine N; Moore DJ
Mol Neurodegener; 2023 Aug; 18(1):51. PubMed ID: 37542299
[TBL] [Abstract][Full Text] [Related]
9. Retromer's Role in Endosomal Trafficking and Impaired Function in Neurodegenerative Diseases.
Follett J; Bugarcic A; Collins BM; Teasdale RD
Curr Protein Pept Sci; 2017; 18(7):687-701. PubMed ID: 26965691
[TBL] [Abstract][Full Text] [Related]
10. Parkinson's disease-linked
Chen X; Kordich JK; Williams ET; Levine N; Cole-Strauss A; Marshall L; Labrie V; Ma J; Lipton JW; Moore DJ
Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5765-5774. PubMed ID: 30842285
[TBL] [Abstract][Full Text] [Related]
11. Formation of retromer transport carriers is disrupted by the Parkinson disease-linked Vps35 D620N variant.
Cui Y; Yang Z; Flores-Rodriguez N; Follett J; Ariotti N; Wall AA; Parton RG; Teasdale RD
Traffic; 2021 Apr; 22(4):123-136. PubMed ID: 33347683
[TBL] [Abstract][Full Text] [Related]
12. The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.
Mir R; Tonelli F; Lis P; Macartney T; Polinski NK; Martinez TN; Chou MY; Howden AJM; König T; Hotzy C; Milenkovic I; Brücke T; Zimprich A; Sammler E; Alessi DR
Biochem J; 2018 Jun; 475(11):1861-1883. PubMed ID: 29743203
[TBL] [Abstract][Full Text] [Related]
13. Role of the VPS35 D620N mutation in Parkinson's disease.
Mohan M; Mellick GD
Parkinsonism Relat Disord; 2017 Mar; 36():10-18. PubMed ID: 27964832
[TBL] [Abstract][Full Text] [Related]
14. Endosomal Trafficking in Alzheimer's Disease, Parkinson's Disease, and Neuronal Ceroid Lipofuscinosis.
Qureshi YH; Baez P; Reitz C
Mol Cell Biol; 2020 Sep; 40(19):. PubMed ID: 32690545
[TBL] [Abstract][Full Text] [Related]
15. VPS35 Downregulation Alters Degradation Pathways in Neuronal Cells.
Filippone A; Li JG; Praticò D
J Alzheimers Dis; 2021; 84(3):1079-1089. PubMed ID: 34602481
[TBL] [Abstract][Full Text] [Related]
16. The Parkinson's disease related mutant VPS35 (D620N) amplifies the LRRK2 response to endolysosomal stress.
McCarron KR; Elcocks H; Mortiboys H; Urbé S; Clague MJ
Biochem J; 2024 Feb; 481(4):265-278. PubMed ID: 38299383
[TBL] [Abstract][Full Text] [Related]
17. Mutation in VPS35 associated with Parkinson's disease impairs WASH complex association and inhibits autophagy.
Zavodszky E; Seaman MN; Moreau K; Jimenez-Sanchez M; Breusegem SY; Harbour ME; Rubinsztein DC
Nat Commun; 2014 May; 5():3828. PubMed ID: 24819384
[TBL] [Abstract][Full Text] [Related]
18. Endosomal traffic and glutamate synapse activity are increased in VPS35 D620N mutant knock-in mouse neurons, and resistant to LRRK2 kinase inhibition.
Kadgien CA; Kamesh A; Milnerwood AJ
Mol Brain; 2021 Sep; 14(1):143. PubMed ID: 34530877
[TBL] [Abstract][Full Text] [Related]
19. Reduced retromer function results in the accumulation of amyloid-beta oligomers.
Ansell-Schultz A; Reyes JF; Samuelsson M; Hallbeck M
Mol Cell Neurosci; 2018 Dec; 93():18-26. PubMed ID: 30257187
[TBL] [Abstract][Full Text] [Related]
20. Contributions of VPS35 Mutations to Parkinson's Disease.
Rahman AA; Morrison BE
Neuroscience; 2019 Mar; 401():1-10. PubMed ID: 30660673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
